yoylqnqvwb
Cholerny Spammer
Joined: 03 Mar 2011
Posts: 729
Read: 0 topics
Location: England
|
Posted: Wed 13:40, 09 Mar 2011 Post subject: keen shoes sale cur eka bmr vme |
|
|
Hormone refractory prostate cancer treatment
MolecularMorphology ,2005,13:6-13 .12 DiPaolaRS. Approachestothetreatmentofpatientswithhormone-sensitiveprostatecancer. SeminOnco1, 1999,26 (5Supp117): $ 24 a S27.13DipaolaRS, ManolaJ, LiS, eta1. ArandomizedphaseIItria1ofmitoxantrone,[link widoczny dla zalogowanych], estramustineandvinorelbineor13-cisretinoicacid,[link widoczny dla zalogowanych], interferonandpaclitaxe1inpatientswithmetastatichormonerefractoryprostatecancer: ResultsofEC0G3899. ProcAmScoClinOncol (PostMeetingEdition), 2004,22:14 S. 14DahutWL, GulleyJI, ArlenPM, eta1. RandomisedphaseIItria1ofdocetaxe1plusthalidomideinandrogen-independentprostatecancer. JClinOnco1,[link widoczny dla zalogowanych], 2004,22 (3) :2532-2539 .15 Smal1E,[link widoczny dla zalogowanych], SchellhammerP, HiganoC, eta1. Placebo-ControlledPhaseIIITrialofImmunologicTherapywithSipuleucel-T (APC8O15) inPatientswithMetastatic, AsymptomaticHormoneRefractoryProstateCancer. JClinOnco1 ,2006,24:3089-3094 .16 GoldenbergAL, BruchovskyN, GleaveME, eta1. Intermittentandrogensuppressioninthetreatmentofprostatecancer: apreliminaryreport. Urology ,1995,45:839-944 .17 GrossfeldGD, ChaudharyUB,[link widoczny dla zalogowanych], ReeseDM, eta1. Intermittentandrogendeprivation: updateofcyclingcharacteristicsinpatientswithoutclinicallyapparentmetastaticprostatecancer. Urology ,2001,58:240-245 .18 SmithMR, LeeH, NathanDM. InsulinSensitivityduringCombinedAndrogenBlockadeforProstateCancer. JClinEndocrino1Metab, 2006,91 (4): 130513O8.
The post has been approved 0 times
|
|